These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19463356)

  • 1. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
    John MC; Wessely R; Kastrati A; Schömig A; Joner M; Uchihashi M; Crimins J; Lajoie S; Kolodgie FD; Gold HK; Virmani R; Finn AV
    JACC Cardiovasc Interv; 2008 Oct; 1(5):535-44. PubMed ID: 19463356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.
    Steigerwald K; Ballke S; Quee SC; Byrne RA; Vorpahl M; Vogeser M; Kolodgie F; Virmani R; Joner M
    EuroIntervention; 2012 Oct; 8(6):752-9. PubMed ID: 23086794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents.
    Mori H; Cheng Q; Lutter C; Smith S; Guo L; Kutyna M; Torii S; Harari E; Acampado E; Joner M; Kolodgie FD; Virmani R; Finn AV
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2375-2387. PubMed ID: 29102583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
    Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolute and Xience V polymer-based drug-eluting stents compared in an atherosclerotic rabbit double injury model.
    Van Dyck CJ; Hoymans VY; Bult H; Fransen E; Haine S; Bosmans JM; Timmermans JP; Vrints CJ
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):E259-68. PubMed ID: 22887820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
    Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular responses to a biodegradable polymer (polylactic acid) based biolimus A9-eluting stent in porcine models.
    Hagiwara H; Hiraishi Y; Terao H; Hirai T; Sakaoka A; Sasaki M; Murota S; Inoue K; Kimura J
    EuroIntervention; 2012 Oct; 8(6):743-51. PubMed ID: 23086793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
    Finn AV; Kolodgie FD; Harnek J; Guerrero LJ; Acampado E; Tefera K; Skorija K; Weber DK; Gold HK; Virmani R
    Circulation; 2005 Jul; 112(2):270-8. PubMed ID: 15998681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
    Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
    Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model.
    Cilingiroglu M; Elliott J; Sangi P; Matthews H; Tio F; Trauthen B; Elicker J; Bailey SR
    EuroIntervention; 2009 Jan; 4(4):534-41. PubMed ID: 19284078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
    Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
    Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
    Sperling C; Waliszewski MW; Kherad B; Krackhardt F
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization.
    Nakazawa G; Granada JF; Alviar CL; Tellez A; Kaluza GL; Guilhermier MY; Parker S; Rowland SM; Kolodgie FD; Leon MB; Virmani R
    JACC Cardiovasc Interv; 2010 Jan; 3(1):68-75. PubMed ID: 20129572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents.
    Li J; Jabara R; Pendyala L; Otsuka Y; Shinke T; Hou D; Robinson K; Chronos N
    JACC Cardiovasc Interv; 2008 Jun; 1(3):279-85. PubMed ID: 19463313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct stenting limits sirolimus-eluting stent edge neointimal thickening.
    Guérin P; Gouëffic Y; Heymann MF; Pillet P; Al Habash O; Crochet D; Pacaud P; Loirand G
    J Vasc Surg; 2007 Aug; 46(2):354-9. PubMed ID: 17664110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).
    Spaulding C; Teiger E; Commeau P; Varenne O; Bramucci E; Slama M; Beatt K; Tirouvanziam A; Polonski L; Stella PR; Clugston R; Fajadet J; de Boisgelin X; Bode C; Carrié D; Erglis A; Merkely B; Hosten S; Cebrian A; Wang P; Stoll HP; Henry P
    JACC Cardiovasc Interv; 2011 Jan; 4(1):14-23. PubMed ID: 21251624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
    van der Giessen WJ; Sorop O; Serruys PW; Peters-Krabbendam I; van Beusekom HM
    JACC Cardiovasc Interv; 2009 Apr; 2(4):284-90. PubMed ID: 19463438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.